Skip to content
Log in
Sponsored Design Multi-Agent AI Systems Using MCP and A2A: Engineer your own Pyt Design Multi-Agent AI Systems Using MCP and A2A: Engineer your own Pyt

Author

RamaRao Malla

h-index 7 View on Semantic Scholar

We have 3 of 15 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Aug 2026

Baicalein targets the Nrf2/Keap1 interaction and related stress pathways to mitigate drug-induced toxicity and reverse resistance in breast cancer: A review.

The cellular stress mediator Nrf2 and its negative regulator Keap1 are frequently dysregulated across breast cancer subtypes. As a master regulator of stress-related pathways, the Nrf2/Keap1 complex drives either cytoprotection or cell death, depending on the cellular context. Furthermore, its roles in promoting drug r...

Anuveda Sree Samudrala, G. Nagaraju, RamaRao Malla · 0 citations
Review Aug 2026

From intercellular communication to therapeutic delivery: Mechanistic perspectives of cancer exosomes.

This review details the role of tumor derived exosomes in shaping an immunosuppressive TME, especially their capacity to modulate T-cell function, polarize myeloid cells, and influence immune checkpoint signalling, and discusses emerging therapeutic strategies aimed at intercepting or reprogramming exosomal cargo.

RamaRao Malla, G. Nagaraju · 0 citations
Review Aug 2026

Systemic therapy-induced resistance and toxicity in breast cancer: Sensitization and mitigation strategies.

This review uncovers recent updates on acquired resistance mechanisms toward standard-of-care treatments driven by deeply rooted heterogeneity and aggressive nature and helps to identify novel strategies targeting pathways to reverse resistance and reduce toxicity in breast cancer patients.

Anuveda Sree Samudrala, G. Nagaraju, RamaRao Malla · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.